Dr Lal PathLabs Completes 80% Stake Acquisition In Ghana's Sunshine Healthcare
Mumbai: Dr Lal PathLabs ' wholly owned subsidiary in Dubai, Dr Lal PathLabs FZCO (DLPL Dubai), has completed the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL) in Ghana. The acquisition makes SHL a step-down subsidiary of Dr Lal PathLabs. Acquisition Details The acquisition was completed in accordance with the agreement and prevailing provisions applicable in Ghana. This follows…
Dr Lal PathLabs, a wholly-owned subsidiary based in Dubai, has finalized the acquisition of an 80% stake in Ghanaian healthcare company Sunshine Healthcare Limited (SHL). This acquisition transforms SHL into a subsidiary under Dr Lal PathLabs' ownership. The deal adhered to the guidelines set by Ghanaian regulations, following a board approval announced on July 24, 2026.
The acquisition is part of Dr Lal PathLabs' strategy to broaden its global presence, particularly in Africa, through its Dubai-based entity. This move expands the company's international reach and signifies a major step in its growth trajectory. Prior to this announcement, SEBI had provided guidelines on July 13, 2023. This report is based on company filings and intended for informational purposes only, advising investors to consider the associated risks before making any investment decisions.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
